Tenax Therapeutics (TENX) Operating Leases (2019 - 2022)
Tenax Therapeutics (TENX) posted quarterly Operating Leases of $183589.0 for Q4 2022, down 36.86% year-over-year from $290781.0 in Q4 2021, and down 13.23% on a QoQ basis from $211590.0 in Q3 2022.
Tenax Therapeutics (TENX) Operating Leases (2019 - 2022) Analysis & Trends
Tenax Therapeutics has reported Operating Leases for 4 years, with the latest figure at $183589.0 in Q4 2022.
- Operating Leases for Q4 2022 came in at $183589.0, down 36.86% year-over-year; the trailing twelve-month figure through Dec 2022 was $183589.0 (down 36.86% YoY), and the FY2022 annual result was $183589.0, down 36.86% from the prior year.
- Operating Leases retreated to $183589.0 in Q4 2022, from $211590.0 in the prior quarter.
- Over five years, Operating Leases peaked at $340500.0 in Q2 2021 and troughed at $30743.0 in Q1 2020.
- A 4-year average of $187864.6 and a median of $197589.5 in 2022 frame the typical range for Operating Leases.
- The widest annual swing landed in 2020, when Operating Leases sank 70.07%; it then retreated 29.8% in 2022.
- A 4-year view of Operating Leases shows it stood at $60379.0 in 2019, then sank by 49.08% to $30743.0 in 2020, then soared by 845.84% to $290781.0 in 2021, then plunged by 36.86% to $183589.0 in 2022.
- Per Business Quant data, the three most recent Operating Leases figures were $183589.0 in Q4 2022, $211590.0 in Q3 2022, and $239039.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 64,196.00 |
| Sep 30, 2022 | 95,347.00 |
| Jun 30, 2022 | 125,883.00 |
| Mar 31, 2022 | 155,024.00 |
| Dec 31, 2021 | 183,589.00 |
| Sep 30, 2021 | 211,590.00 |
| Jun 30, 2021 | 239,039.00 |
| Mar 31, 2020 | 30,743.00 |
| Dec 31, 2019 | 60,379.00 |
| Sep 30, 2019 | 108,421.00 |
| Jun 30, 2019 | 105,547.00 |
| Mar 31, 2019 | 102,730.00 |